SMTL ID : 9c1r.1

Crystal structure of mutant cMET D1228N kinase domain in complex with inhibitor compound 13

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.59 Å

Oligo State

monomer

Ligands

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 4 residues within 4Å: Chain A: H.128, P.130, H.303, H.304 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:H.128

1 x 01: N-(2,5-difluoro-4-{[(1s,3S)-3-(1-methyl-1H-pyrazol-3-yl)cyclobutyl][(8R)-pyrazolo[1,5-a]pyrazin-4-yl]amino}phenyl)-2-(5-fluoropyridin-2-yl)-3-oxo-2,3-dihydropyridazine-4-carboxamide

01.2: 24 residues within 4Å: Chain A: I.38, G.39, R.40, V.46, A.62, K.64, E.81, I.84, M.85, F.88, V.93, L.94, L.111, P.112, Y.113, M.114, L.149, F.154, H.156, M.165, V.174, A.175, D.176, F.177 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:I.38, A:V.46, A:A.62, A:K.64, A:F.88, A:V.93, A:L.111, A:F.177, A:F.177, A:F.177 Hydrogen bonds: A:M.114, A:D.176 Water bridges: A:K.64

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bumpers, Q.A. et al., Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy. J.Med.Chem. (2024)

Release Date

2024-08-21

Peptides

Hepatocyte growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Hepatocyte growth factor receptor